Ami Ben Ya'acov

Dr. Ami Ben Ya'acov

orcid

Research Focus & Metrics

Academic Career Length

13Years (2014-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 January 2021 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
RSRonen Sadeh
Ronen Sadeh
ISIsraa Sharkia
Israa Sharkia
GFGavriel Fialkoff
Gavriel Fialkoff
ARAyelet Rahat
Ayelet Rahat
JGJenia Gutin
Jenia Gutin
NFNir Friedman
Nir Friedman

7 May 2015 in Digestive Diseases and Sciences
Verified
Journal Article
Closed access
PDF file
TATomer Adar
Tomer Adar
SGSorina Grisaru-Granovsky
Sorina Grisaru-Granovsky
AYAmi Ben Ya'acov
Ami Ben Ya'acov
EGEran Goldin
Eran Goldin
ASAriella Bar-Gil Shitrit
Ariella Bar-Gil Shitrit

1 October 2014 in Journal of Inflammation Research
Verified
Journal Article
Open access
AYAmi Ben Ya'acov
Ami Ben Ya'acov
EZEhud Zigmond
Ehud Zigmond
Oshrat E. Tayer-ShifmanOshrat E. Tayer-Shifman
Oshrat E. Tayer-Shifman
GLGadi Lalazar
Gadi Lalazar
SZSarah Zangen
Sarah Zangen
Itamar RazItamar Raz
Itamar Raz
Liver steatosis is a common characteristic of obesity and type 2 diabetes, and fatty liver disease is increasingly recognized as a major health burden. Accumulating evidence suggests that β-glycosphingolipids play an important role in insulin sensitivity and thus could affect hepatic steatosis. To determine the effect associated with β-glycosphingolipid-mediated amelioration of liver injury, seven groups of Psammomys obesus on a high-energy diet were studied. Animals were treated with daily injections of β-glucosylceramide, β-lactosylceramide, or a combination of both. β-glycosphingolipids ameliorated the hepatic injury manifested by decreased liver enzymes, liver weight, and hepatic fat, and improved liver histology. Administration of both β-glucosylceramide and β-lactosylceramide also decreased interferon (IFN)-γ serum levels. These effects were associated with improved serum cholesterol and triglyceride levels. These data suggest that β-glycosphingolipids ameliorate liver injury in an animal model of nonalcoholic steatohepatitis.

1 March 2021 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
RSRonen Sadeh
Ronen Sadeh
ISIsraa Sharkia
Israa Sharkia
GFGavriel Fialkoff
Gavriel Fialkoff
ARAyelet Rahat
Ayelet Rahat
JGJenia Gutin
Jenia Gutin
NFNir Friedman
Nir Friedman

1 January 2019 in Toxicology and Applied Pharmacology
Verified
Journal Article
Closed access
ESEyal Shteyer
Eyal Shteyer
AYAmi Ben Ya'acov
Ami Ben Ya'acov
LZLidia Zolotaryova
Lidia Zolotaryova
ASAvital Sinai
Avital Sinai
MSMordechai Slae
Mordechai Slae
YIYaron Ilan
Yaron Ilan

23 March 2017 in BMC Gastroenterology
Verified
Journal Article
Open access
PDF file
AYAmi Ben Ya'acov
Ami Ben Ya'acov
HMHadar Meir
Hadar Meir
LZLydia Zolotaryova
Lydia Zolotaryova
Yaron IlanYaron Ilan
Yaron Ilan
ESEyal Shteyer
Eyal Shteyer
It has been shown that the proportion of natural killer T cells is markedly elevated during liver regeneration and their activation under different conditions can modulate this process. As natural killer T cells and liver injury are central in liver regeneration, elucidating their role is important. The aim of the current study is to explore the role of natural killer T cells in impaired liver regeneration. Concanvalin A was injected 4 days before partial hepatectomy to natural killer T cells- deficient mice or to anti CD1d1-treated mice. Ki-67 and proliferating cell nuclear antigen were used to measure hepatocytes proliferation. Expression of hepatic cyclin B1 and proliferating cell nuclear antigen were evaluated by Western Blot and liver injury was assessed by ALT and histology. Natural killer T cells- deficient or mice injected with anti CD1d antibodies exhibited reduced liver regeneration. These mice were considerably resistant to ConA-induced liver injury. In the absence of NKT cells hepatic proliferating cell nuclear antigen and cyclin B1 decreased in mice injected with Concanvalin A before partial hepatectomy. This was accompanied with reduced serum interleukin-6 levels. Natural killer T cells play an important role in liver regeneration, which is associated with cyclin B1 and interleukin-6.